Get started
Author

Lothar T. Tremmel

Phase III Randomized Study of Bendamustine Compared With Chlorambucil in Previously Untreated Patients With Chronic Lymphocytic Leukemia
2009 · Wolfgang U. Knauf, Toshko Lissichkov, et al. · Journal of Clinical Oncology · 444
PDF
Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse
2011 · Mark Levis, Farhad Ravandi, et al. · Blood · 398
A Randomized, Placebo-controlled Study of Fentanyl Buccal Tablet for Breakthrough Pain in Opioid-treated Patients With Cancer
2006 · Russell K. Portenoy, Donald Taylor, et al. · Clinical Journal of Pain · 223
A Randomized, Open-Label Study of Lestaurtinib (CEP-701), an Oral FLT3 Inhibitor, Administered in Sequence with Chemotherapy in Patients with Relapsed AML Harboring FLT3 Activating Mutations: Clinical Response Correlates with Successful FLT3 Inhibition.
2005 · Mark Levis, B. Douglas Smith, et al. · Blood · 57
Bendamustine Produces Durable Responses With an Acceptable Safety Profile in Patients With Rituximab-Refractory Indolent Non-Hodgkin Lymphoma
2010 · Bruce D. Cheson, Jonathan W. Friedberg, et al. · Clinical Lymphoma Myeloma & Leukemia · 56
Results From a Randomized Trial of Salvage Chemotherapy Followed by Lestaurtinib for FLT3 Mutant AML Patients in First Relapse.
2009 · Mark Levis, Farhad Ravandi, et al. · Blood · 32
The Visual Separability of Plotting Symbols in Scatterplots
1995 · Lothar Tremmel · Journal of Computational and Graphical Statistics · 25
Adjusting for Ordinal Covariates by Inducing a Partial Ordering
2004 · Vance W. Berger, YanYan Zhou, et al. · Biometrical Journal · 24
Aggregate Safety Assessment Planning for the Drug Development Life-Cycle
2021 · Barbara A. Hendrickson, William Wang, et al. · Therapeutic Innovation & Regulatory Science · 20
A Bayesian adaptive design for multi-dose, randomized, placebo-controlled phase I/II trials
2012 · Fang Xie, Yuan Ji, et al. · Contemporary Clinical Trials · 14
Using Meddra for Adverse Events in Cancer Trials: Experience, Caveats, and Advice
2001 · Lothar T. Tremmel, Lynn Scarpone · Drug Information Journal · 13
Global Regulatory Landscape for Aggregate Safety Assessments: Recent Developments and Future Directions
2020 · Greg Ball, Raffael Kurek, et al. · Therapeutic Innovation & Regulatory Science · 9
PDF
Bendamustine Produces Durable Responses with An Acceptable Long-Term Safety Profile in Patients with Rituximab-Refractory Non-Hodgkin's Lymphoma: A Pooled Analysis.
2009 · Bruce D. Cheson, Jonathan W. Friedberg, et al. · Blood · 7
Value and Implementation of the Aggregate Safety Assessment Plan
2023 · Barbara A. Hendrickson, Anupam Agarwal, et al. · Pharmaceutical Medicine · 4
(312/729)
2006 · D. Taylor, R. Portenoy, et al. · Journal of Pain · 4
Lateral differences indicate future glaucoma
1992 · Adelheid Th�len, Lothar Tremmel, et al. · Graefe s Archive for Clinical and Experimental Ophthalmology · 4
Global Landscape of Benefit–Risk Considerations for Medicinal Products: Current State and Future Directions
2022 · Max Waschbusch, Lisa Rodriguez, et al. · Pharmaceutical Medicine · 3
Monitoring of Aggregate Safety Data in Clinical Development
2021 · Lothar Tremmel, Barbara Hendrickson · Chapman & Hall/CRC eBooks · 3
Cerebrospinal fluid haptoglobin levels and outcome after aneurysmal subarachnoid haemorrhage: Evidence from Mendelian randomization
2025 · Gbenga A. Kayode, Loukas Zagkos, et al. · PLoS ONE · 2
PDF
A visual safety risk evaluation tool in early clinical phases
2025 · Kathrin Wawra-Hehenberger, Vanessa Pencelli, et al. · Contemporary Clinical Trials · 2
Statistical Inference after an Adaptive Group Sequential Design: A Case Study
2010 · Lothar T. Tremmel · Drug Information Journal · 2
Global Regulatory Landscape for Aggregate Safety Assessments: Recent Developments and Future Directions
2019 · Greg Ball, Raffael Kurek, et al. · Therapeutic Innovation & Regulatory Science · 1
Are Patient or Disease Characteristics Associated with Complete Response or Progression During Bendamustine-Rituximab Treatment in Previously Treated Patients with Non-Hodgkin's Lymphoma?.
2009 · Mkaya Mwamburi, Gayatri Ranganathan, et al. · Blood · 1
A New Look at Evaluating MTD Designs in Cancer Research
2009 · L. T. Tremmel · Journal of Statistical Theory and Practice · 1
Comment on “A Model for Studying Display Methods of Statistical Graphics”
1993 · Lothar Tremmel · Journal of Computational and Graphical Statistics · 1
Works count: 29
Citation count: 1,350
H-index: 11
I10-index: 11
Year
Topic
Type